<DOC>
	<DOCNO>NCT00365872</DOCNO>
	<brief_summary>This Phase II study use combination external beam radiation intratumoral injection dendritic cell ( white blood cell ) neo-adjuvant treatment patient high-risk soft tissue sarcoma . The purpose determine injection patient 's immune relate white blood cell tumor would strengthen immune system fight cancer .</brief_summary>
	<brief_title>External Beam Radiation With Intratumoral Injection Dendritic Cells As Neo-Adjuvant Treatment Sarcoma</brief_title>
	<detailed_description>Patients treat external beam radiation therapy ( EBRT ) combine experimental intratumoral injection dendritic cell ( DC ) . Patients receive 5,040 centigray ( cGy ) EBRT 28 equal fraction . Radiation deliver 5 day per week ( Monday-Friday ) . DCs ( 10^7 cell ) inject intratumorally three time second , third , fourth Friday course radiation . One additional DC injection give several day surgery ass DC migration . Tumors surgically resect 3-6 week completion EBRT .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<criteria>Intermediate high grade sarcoma determine pathology review Musculoskeletal tumor extremity , trunk chest wall . Primary tumor isolate locally recurrent tumor great 5 cm diameter . Clinical Stage T2N0M0 ( AJCC 6th edition ) Patient candidate neoadjuvant chemotherapy . Performance status Eastern Cooperative Oncology Group ( ECOG ) 0 1 . No steroid therapy within 4 week first dendritic cell administration . No coagulation disorder . Patient 's write informed consent . No contraindication resection . Adequate organ function ( measure within week begin treatment ) . White blood count ( WBC ) &gt; 3,000/mm third power absolute neutrophil count ( ANC ) &gt; 1500/mm third power Platelets &gt; 100,000/mm third power Hematocrit &gt; 25 % Bilirubin &lt; 2.0 mg/dL Creatinine &lt; 2.0 mg/dL , creatinine clearance &gt; 60 mL/min Radiation Oncologist must confirm 23 cm strip skin spar radiation . Retroperitoneal location . Gastrointestinal stromal tumor ( GIST ) . Demonstrated metastatic disease . Prior radiation therapy current tumor locally recurrent prior resection . Concurrent treatment anticancer agent radiation dictate protocol . Bleeding disorder . H.I.V . infection primary immunodeficiency disorder . Ongoing systemic therapy immunosuppressant drug ( e.g . corticosteroid , azathioprine , cyclosporin , methotrexate ) . Any serious ongoing infection . Pregnant lactating woman Patients reproductive age must agree use contraceptive method duration study ( pregnancy test obtain treatment ) . ECOG performance status 2 , 3 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Sarcoma</keyword>
	<keyword>Intratumoral injection</keyword>
	<keyword>Dendritic cell</keyword>
	<keyword>Neo-adjuvant treatment</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Pheresis</keyword>
	<keyword>Radiation</keyword>
</DOC>